Clinical Trial Update: VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management

View source ↗

Summary

Update on a pharmacogenomics study examining how VKORC1 and CYP2C9 polymorphisms affect warfarin management across several indications, including atrial fibrill…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Deep Vein Thrombosis
• Dilated Cardiomyopathy
• Intracardiac Thrombus
• Ischemic Cardiomyopathy
• Peripheral Vascular Disease
• Pulmonary Embolism
• Valvular Heart Disease

Drugs mentioned

• Warfarin (warfarin)

Snippet

Sponsor: Ankara University | Conditions: Atrial Fibrillation, Cardiac Thrombus | Status: UNKNOWN